These results indicate that mitochondrial mTOR may not be a feature unique to tumor cells, but an opportunistic reprogramming of cellular metabolism from glycolysis to mitochondrial oxidative respiration, potentially providing extra energy to address genotoxic changes, enhancing tumor cell survival. The gene discussed is MTOR; the disease is neoplasm.